Michael B. Harlin
Advertisement
Partner at Neal Gerber Eisenberg, specializing in life sciences intellectual property.
Articles by Michael B. Harlin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Stock Reacts to Unsuccessful Phase III Trial Results
2
What Does the List of Approved Drugs Reveal About FDA's Priority Review Voucher Program?
3
Winning the Next Era of Direct-to-Patient Drug Distribution: Why End-to-End Integration Matters More Than Assembly
4
What Successes and Setbacks Occurred in Neurosciences in 2025?
5
